Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells

Vascular Pharmacology

Volumn 40, Issue 6, 2004, Pages 269-277

  Chen, W ^a   Valamanesh, F ^a   Mirshahi, T ^a   Soria, J ^a   Tang, R ^a   Agarwal, M K ^a   Mirshahi, M ^a,b  

^a CNRS   (France)

^b INSERM   (France)

Author keywords

Aldosterone; Amiloride; Angiogenesis; Endothelium; Receptors; Sodium channel

Indexed keywords

ALDOSTERONE; AMILORIDE; FIBRIN; GLUTAMINYLGLYCYLLEUCYLGLYCYLLYSYLGLYCYLASPARTYLLYSYLARGINYLGLUTAMYLGLUTAMYL GLYCYLLEUCINE; MATRIGEL; MEMBRANE PROTEIN; PEPTIDE DERIVATIVE; SODIUM CHANNEL; SODIUM ION; TUBULIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ARTICLE; BONE MARROW CELL; CAPILLARY FLOW; CELL CULTURE; CELL MIGRATION; CELL NUCLEUS; CELL SWELLING; CELL VOLUME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALDOSTERONE; AMILORIDE; BLOTTING, WESTERN; BONE MARROW CELLS; CAPILLARIES; CELL LINE; DIURETICS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; PROTEIN SUBUNITS; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; SODIUM CHANNELS; TUBULIN;

EID: 1842477357     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2003.08.003     Document Type: Article

References (26)

1. Agarwal M.K. Perspectives in receptor-mediated mineralocorticoid hormone action. Pharmacol. Rev. 46:1994;67-87.
2. Agarwal M.K., Mirshahi M. General overview of mineralocorticoid hormone action. Pharmacol. Ther. 84:1999;273-326.
3. Alliegro M.C., Alliegro M.A., Cragoe E.J., Glaser B.M. Amiloride inhibition of angiogenesis in vitro. J. Exp. Zool. 267:1993;245-252.
4. + absorption. Am. J. Physiol. 273:1997;G571-G585.
5. Eaton D.C., Becchetti A., Ma H., Ling B.N. Renal sodium channels: regulation and single channel properties. Kidney Int. 48:1995;941-949.
6. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
7. Garty H., Palmer L.G. Epithelial sodium channels: function, structure and diversity. Physiol. Rev. 77:1997;359-396.
8. Golestaneh N., Valamanesh F., Klein C., Agarwal M.K., Mirshahi M. Mineralocorticoid receptor-mediated signalling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem. Biophys. Res. Commun. 280:2001;1300-1306.
9. Griffionen A.W., Molema J. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52:2000;237-268.
10. Hatakeyama H., Miyamori I., Fujita T., Takeda Y., Takeda R., Yamamoto H. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J. Biol. Chem. 269:1994;24316- 24320.
11. Hyder S.M., Stancel G.M. Regulation of VEGF in the reproductive tract by sex steroid hormones. Histol. Histopathol. 15:2000;325-334.
12. Knoll A., Schmidt S., Chapman M., Wiley D., Bulgrin J., Blank J., Kirchner L. A comparison of two controlled-release delivery systems for the delivery of amiloride to control angiogenesis. Microvasc. Res. 58:1999;1-9.
13. Kolch W., Baron G.M., Kieser A., Marme D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. 36:1995;139-155.
14. Koli K., Oja K.J. Transforming growth factor beta system and its regulation by members of the steroid-thyroid hormone superfamily. Adv. Cancer Res. 70:1996;63-94.
15. Lehr J.E., Pienta K.J. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J. Natl. Cancer Inst. 90:1998;118-123.
16. Lifton R.P. Genetic determinants of human hypertension. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8545-8551.
17. Lifton R.P., Dluhy R.G., Powers M., Rich G.M., Cook S., Ulick S., Lalouel J.M. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 355:1992;262-265.
18. Macknight A.D.C., DiBona D.R., Leaf A. Sodium transport across toad urinary bladder: a model tight epithelium. Annu. Rev. Physiol. 60:1980;615-715.
19. Mengelsdorf D.J., Thummel C., Beato M., Herrlich P., Scütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
20. Mirshahi M., Mirshahi S., Golestaneh N., Mishal Z., Nicolas C., Hecquet C., Agarwal M.K. Demonstration of the mineralocorticoid hormone receptor and action in human leukemic cell lines. Leukemia. 14:2000;1093-1100.
21. Mirshahi M., Golestaneh N., Valamanesh F., Agarwal M.K. Paradoxical effects of mineralocorticoids on the ion gated sodium channel in embryologically diverse cells. Biochem. Biophys. Res. Commun. 270:2000;811-815.
22. Mirshahi M., Mirshahi S., Nicolas C., Golestaneh N., Mishal Z., Lounes K.C., Hecquet C., Dagonet F., Pouliquen Y., Agarwal M.K. Mineralocorticoid hormone signalling regulates the 'epithelial sodium channel' in fibroblasts from human cornea. Ophthalmic Res. 33(7-19):2000;. (2001).
23. Nelhes V., Drencklam D. A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three dimensional fibrin matrices in vitro. Histochem. Cell Biol. 104:1995;459-466.
24. Rossier B.C., Canessa C.M., Schild L., Horisberger J.D. Epithelial sodium channels. Curr. Opin. Nephrol. Hypertens. 3:1994;487-496.
25. Schultz S.G. A century of (epithelial) transport physiology: from vitalism to molecular cloning. J. Physiol. 274:1998;C13-C23. (Cell Physiol. 43).
26. Sood A.K., Gupta B., Chugh P. Topical amiloride application accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits. Methods Find Exp. Clin. Pharmacol. 21:1999;491-497.